Skip to main content
. 2018 Sep 10;2018:5810767. doi: 10.1155/2018/5810767

Figure 4.

Figure 4

The prophylaxis-therapy regimen with FT reduces P. aeruginosa loads after infection with antibiotic-resistant P. aeruginosa clinical isolates of exoU+ (1840) and exoS+(KB6) genotypes. A/Sn mice were infected with 7x106 CFU/mouse of P. aeruginosa clinical isolate 1840 ((a), group 1); with 3.5x106 CFU/mouse of P. aeruginosa clinical isolate 1840 ((b), group 2); with 1.75x107 CFU/mouse of P. aeruginosa clinical isolate KB6 ((c), group 1); with 8x106 CFU/mouse of P. aeruginosa clinical isolate KB6 ((d), group 2). Mice were treated with 100 mg/kg of FT per os once a day for 2 days before infection and with 50 mg/kg of FT twice a day for 4 days starting immediately after infection. Bacterial loads in lungs, spleens, and blood of survived animals were analyzed at day 5 postinfection. Black bars, mice not treated with FT; dotted bars, mice treated with FT, P < 0.05.